3 Followers USX:A - Agilent Technologies Inc. (USD 78.33) Agilent Technologies Inc.
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist

Yahoo Finance

USD 78.33    +1.640 (+2.14%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

9 Apr 2020


9 Apr 2020

Day Change: 1.640 (2.14%)

52 Wk Range: 61.13 - 90.64

Day's Range: 76.2268 - 78.72

Last Volume: 2,247,791

Current Yield: 0.88%

Projected Yield: 0.88%

Open: USD 76.43

9 Apr 2020

Metric A S.Median
Beta 1 0.84
VaR 18.23 25.23
E.Shortfall 27.98 45.03
Liquidity 2.24M 95.2K


9 Apr 2020

PE: 23.258

Market Cap: 24.9B

Price Over Book: 5.246

Price Over Sales: 4.82

Return On Assets: 11.3%

Return On Equity: 22.6%

Price Over NAV: [Friends Only]


CEO: Michael R. McMullen

Headquarters: Santa Clara

Employees: 14,800

Sector: Health Technology

Industry: Medical Specialties

Useful Links


Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. Its Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The company's Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. Its Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies; and startup, operational, training, and compliance support, as well as asset management and consultation services. The company markets and sells its products through direct sales, electronic commerce, resellers, manufacturers' representatives, and distributors. It has a collaboration agreement with University of Leuven to focus on detecting genetic abnormalities in cell-free DNA and embryo biopsies. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.